Related by context. All words. (Click for frequent words.) 75 kg m² 67 BMI ≥ 66 #kg/m# 64 mmol l 63 ng mL 63 index BMI 62 BMI #-#.# 62 mU L 62 fasting triglyceride levels 62 nmol L 62 highest tertile 61 mIU L 61 mmol L 60 nondiabetic 60 ng dL 60 MetS 60 mg dL 60 hypogonadal 60 nonfasting triglyceride levels 60 ml kg 60 nonobese 60 -#.# ± [001] 59 mEq L 59 baseline HbA1c 59 % CI #.#-#.# [002] 59 waist circumferences 59 ng ml 59 umol L 59 glycated hemoglobin levels 59 GSTM1 58 lowest tertile 58 mIU ml 58 g dL 58 ALT elevation 58 serum IGF 58 prepregnancy 58 HbA1C levels 58 CrCl 58 g dl 58 mL min 58 mL/min/#.# m2 58 pg ml 58 pmol L 57 abdominal circumference 57 advanced adenomas 57 #.#mmol l [002] 57 hydroxyvitamin D levels 57 % CI #.#-#.# [006] 57 serum concentrations 57 mL/min/#.# m 2 57 -#.# ± [002] 57 nmol l 57 pg mL 57 creatinine clearance 57 transferrin saturation 57 HbA 1c levels 57 aged ≥ 57 μg dL 57 % CI #.#-#.# [004] 57 #mg/dL [001] 57 Hb A1c 57 creatinine ratio 57 alanine aminotransferase 57 lopinavir r arm 57 nmol L. 57 baseline serum creatinine 57 mg dl 57 sd = 57 per deciliter mg 57 nondiabetic patients 57 urinary albumin excretion 57 REYATAZ r arm 57 CI #.#-#.# [001] 57 μg L 57 indexes BMIs 56 HbA1c levels 56 pmol liter 56 waist circumference measurements 56 highest quintile 56 μmol L 56 prehypertensive 56 diastolic BP 56 % CI #.#-#.# [008] 56 waist girth 56 Viread Emtriva Sustiva 56 vertebral fracture 56 mmHg systolic 56 ≥ 56 Baseline characteristics 56 mmHg diastolic 56 skinfold thickness 56 HOMA IR 56 confidence interval #.#-#.# 56 advanced adenoma 56 serum selenium 56 CI -#.# 56 x ULN 56 adenoma 56 ± SD 56 μg kg 56 osteopenic 56 mmHg 56 erythrocyte sedimentation rate 56 nanograms per 56 MBq 56 confidence interval CI 56 #.#mmol L [001] 56 systolic dysfunction 55 thyrotropin levels 55 mmol liter 55 % Confidence Interval 55 NPH insulin 55 impaired fasting glucose 55 CC genotype 55 P = .# 55 apnea hypopnea index 55 mean baseline HbA1c 55 mild renal impairment 55 central adiposity 55 urinary albumin 55 alanine aminotransferase ALT 55 nmol liter 55 NNT = 55 tertile 55 IDDM 55 #mg/dL [002] 55 prepregnancy BMI 55 CK MB 55 PSA nadir 55 elevated ALT 55 #.#mg/dL 55 nonpregnant women 55 recurrent VTE 55 albumin excretion 55 #.#ng/ml 55 interquartile range 55 #mg/dl 55 -#.# mg dL [002] 55 mmol L. 55 adjunctive placebo 55 #mmHg [002] 55 adiposity 55 mg d 55 endometrial thickness 55 fasting glucose levels 55 TT genotype 55 mU liter 55 #mmHg [001] 55 mm Hg diastolic 55 X ULN 55 advanced neoplasia 55 EDSS score 55 total cholesterol triglycerides 54 pCR 54 Hb A1C 54 aspartate aminotransferase AST 54 leukopenia 54 femoral neck BMD 54 hours postdose 54 mL kg 54 % CI #.#-#.# [007] 54 HIV uninfected 54 elevated hsCRP 54 kcal d 54 CI #.#-#.# [002] 54 mm Hg systolic 54 MADRS score 54 serum creatinine levels 54 microg 54 mass indexes BMIs 54 BRCA1 mutation carriers 54 hip BMD 54 elevated triglyceride levels 54 metabolically healthy 54 hypophosphatemia 54 tertiles 54 colorectal adenoma 54 μg liter 54 leucopenia 54 mm Hg 54 moderate renal impairment 54 MMSE scores 54 waist circumference 54 Hazard Ratio HR 54 male Sprague Dawley 54 #mg/day [001] 54 depressive symptomatology 54 fasting plasma glucose FPG 54 abdominal adiposity 54 bioavailable testosterone 54 gestational diabetes mellitus GDM 54 aminotransferase levels 54 subclinical hyperthyroidism 54 preoperative PSA 54 aspartate aminotransferase 54 serum uric acid 54 mg TID 54 MMSE score 54 HGPIN 54 log# copies mL 54 nmol 54 thyroid hormone levels 54 leukocyte count 54 adiponectin concentrations 54 p = .# [002] 53 serum leptin 53 invasive carcinomas 53 cardio respiratory fitness 53 #OHD levels 53 estimated glomerular filtration 53 NHANES III 53 DAS# [002] 53 Moderate drinkers 53 systolic blood pressures 53 nondiabetics 53 microalbuminuria 53 parous women 53 mmol 53 statin monotherapy 53 μg mL 53 #μg [001] 53 gestational hypertension 53 PaO 2 53 macroalbuminuria 53 A1c levels 53 baseline A1C 53 PREZISTA r arm 53 oxygen desaturation 53 fasting blood glucose 53 troponin T 53 CDAI score 53 sUA 53 HbA 1c 53 atherogenic dyslipidemia 53 euthyroid 53 #.#mmol L [002] 53 mcg mL 53 TEAEs 53 irregular menstrual cycles 53 BMI waist circumference 53 % CI #.#-#.# [003] 53 anemia hemoglobin 53 #.#mmHg 53 mL sec 53 SGPT 53 CI = 53 serum urate levels 53 perimenopausal women 53 CR nPR 53 diastolic hypertension 53 habitual snoring 53 fasting insulin 53 undergoing bariatric surgery 53 normotensive 53 cardiovascular mortality 53 antibody titer 53 preintervention 53 elevated serum creatinine 53 HbA1C 53 % CI #.#-#.# [005] 53 ml min 53 seroconverted 53 Median survival 53 hemoglobin A1c HbA1c 53 severe renal impairment 53 URTI 53 deciliter 53 rs# [003] 53 CIN3 53 RYGB surgery 53 QRS duration 53 hemoglobin A1c levels 53 TAXUS p value 53 biochemical relapse 53 Insulin sensitivity 53 â ‰ ¥ 53 rs# [002] 53 aminotransferases 53 thiazide diuretics 53 IQR 53 normal ULN 53 mg calcium 53 PREZISTA ritonavir 53 carotid stenosis 52 glycated hemoglobin 52 gestational diabetes mellitus 52 fasting triglycerides 52 Fasting blood glucose 52 lispro 52 serum triglycerides 52 cryptorchidism 52 colorectal polyp 52 albumin excretion rate 52 micrograms mcg 52 elevated fasting glucose 52 Fasting glucose 52 serum testosterone 52 transaminases 52 visceral adiposity 52 Triglyceride levels 52 eGFR 52 oxycodone CR 52 dysglycemia 52 ng dl 52 dairy calcium intake 52 intima media thickness 52 dietary calcium intake 52 triglyceride concentrations 52 onset diabetes mellitus 52 cells uL 52 pg g 52 polypoid lesions 52 serum aminotransferase levels 52 CLA supplementation 52 serum potassium levels 52 mg BID dose 52 eosinophil count 52 diastolic blood pressures 52 neutrophil counts 52 macrosomia 52 milligrams mg 52 Waist Circumference 52 HBeAg 52 nondepressed 52 adenomatous polyps 52 hyperlipidaemia 52 μg ml 52 BMI z 52 BMI percentiles 52 lumbar spine BMD 52 transaminase elevations 52 subclinical hypothyroidism 52 urine albumin 52 ug dose 52 HDL2 52 acetabular dysplasia 52 #Gy 52 achieved ACR# 52 atrophic gastritis 52 Breslow thickness 52 transaminase levels 52 polyp recurrence 52 axillary lymph nodes 52 serum ALT 52 HER2 expression 52 poor metabolizers 52 preeclamptic 52 colorectal adenomas 52 adjunctive ABILIFY 52 HIV HCV coinfected 52 μg g 52 baseline FEV 52 mineral density 52 carotid IMT 52 tibiofemoral 52 quetiapine risperidone 52 μmol l 52 proteinuria 52 plasma triglycerides 52 Index CDAI score 52 anovulatory infertility 52 CARDIA 52 fasting glucose 52 pT3 52 abnormal lipid levels 51 ‰ ¥ 51 coronary artery calcification 51 subtrochanteric 51 histologic subtype 51 premenopausal 51 laboratory abnormalities 51 nanomoles per 51 tibolone 51 impaired glucose tolerance 51 fasting plasma glucose 51 sUA levels 51 AOR = 51 m ^ sup 51 definite stent thrombosis 51 -#.# mg dL [001] 51 copies ml 51 Premenopausal women 51 menarche 51 CVD mortality 51 hsCRP levels 51 nonfatal MI 51 LAB GHRH 51 impaired glucose metabolism 51 colorectal neoplasia 51 mild renal insufficiency 51 latent celiac disease 51 Fasting plasma glucose 51 systolic blood pressure 51 mcg BID 51 waist circumference WC 51 IPSS 51 hydroxyvitamin D 51 serum lipid levels 51 insulin detemir 51 lymphocytosis 51 luminal diameter 51 #mg/kg [002] 51 interleukin IL -6 51 undergone radical prostatectomy 51 linoleic acid LA 51 placebo p 51 hypertension diabetes mellitus 51 distal colon cancer 51 diabetes mellitus hypertension 51 dizziness nausea diarrhea 51 oral antidiabetes 51 nonsignificant difference 51 triacylglycerol 51 plasma glucose concentration 51 triacylglycerol concentrations 51 #ng/ml 51 serum estradiol 51 fasting plasma 51 triglycerides HDL 51 p = #.# [002] 51 nanograms milliliter 51 serum potassium 51 metformin monotherapy 51 obstructive coronary artery 51 ECOG PS 51 SRBD 51 calcium intakes 51 hypercholesterolaemia 51 #.#mg/kg [002] 51 density lipoprotein cholesterol 51 hypersomnia 51 N telopeptide 51 infliximab monotherapy 51 systolic BP 51 recurrent wheezing 51 #/#mmHg 51 transaminase elevations greater 51 ejection fractions 51 obese adolescents 51 glimepiride 51 GSTT1 51 thromboembolic events 51 glycated hemoglobin HbA1c 51 glomerular filtration 51 glucose intolerance 51 nulliparous women 51 μg dl 51 hypertensives 51 micrograms mL 51 serum ferritin 51 EDSS scores 51 adverse reactions incidence 51 Severe hypoglycemia 51 hemoglobin concentrations 51 Index CDAI 51 #.#-#.# [011] 51 tHcy 51 comparator arm 51 SGOT 51 somnolence headache 51 -#.# mmol L 51 nonvertebral fractures 51 hyperhomocysteinemia 51 XIENCE V demonstrated 51 cardiorespiratory fitness 51 autonomic dysfunction 51 cells mcL 51 #.#kg #.#lbs 51 titrated glipizide plus 51 specific antigen PSA 51 Crohn Disease Activity 50 serum phosphorus 50 β blockers 50 + PH# 50 serum calcium 50 prevalences 50 hypogonadal men 50 GH deficiency 50 μg d 50 aminotransferase ALT 50 evaluable subjects 50 serum PSA 50 -#.# log# copies mL 50 Rectal cancer 50 fat emboli 50 gallstone disease 50 dizygotic 50 GH deficient 50 -#.# p = 50 primary hypercholesterolemia 50 ìg 50 biliopancreatic diversion 50 mg/# h 50 dyslipidaemia 50 visceral adipose tissue 50 anthropometric measures 50 preoperatively 50 glycosylated hemoglobin HbA1c 50 shorter telomere length 50 timepoint 50 abdominally obese 50 p = #.# [004] 50 flutamide 50 n = 50 plus medroxyprogesterone acetate 50 homocysteine concentrations 50 hematologic toxicity 50 DEXA scan 50 Pred Forte 50 bilateral oophorectomy 50 glulisine 50 distant metastases 50 CRP concentrations 50 elevated triglycerides 50 HBeAg seroconversion 50 Complication rates 50 seropositivity 50 LS BMD 50 Apidra ® 50 BMIs 50 mercury mmHg 50 #mm Hg 50 mg Androxal 50 apolipoprotein B 50 overt hepatic encephalopathy HE 50 biochemical recurrence 50 hs CRP 50 kg -1 50 μg l 50 elevated lipase 50 EQUATE OB 50 folate intake 50 arterial oxygen saturation 50 venous thrombosis 50 millimeters mm 50 hypoxemia 50 folate vitamin B 50 RYGB 50 IU mL 50 plasma folate 50 lymph node involvement 50 serum sodium concentration 50 elevated CRP 50 colorectal carcinoma 50 hypoglycemic events 50 rs# [001] 50 mcg dL 50 pathologic fractures 50 mg QD 50 density BMD 50 serum vitamin D 50 p ≤ 50 hypopneas 50 glargine 50 obese postmenopausal 50 glucose tolerance test 50 oral allopurinol 50 baseline LDH 50 intraabdominal 50 handgrip strength 50 CHD mortality 50 hypocaloric diet 50 OADs 50 liver steatosis 50 ipsilateral stroke 50 SHBG levels 50 underwent resection 50 plasma leptin 50 NAFLD 50 System IPSS 50 Subclinical hypothyroidism 50 macrovascular 50 amenorrhoea 50 CHD CVD 50 Unsaturated fats 50 EBRT 50 rectal temperature 50 abacavir lamivudine 50 arterial stiffness 50 placebo dummy pill 50 Rh + 50 glucose insulin 50 enamel defects 50 F FLT 50 μg dose 50 Gregg Nishi 50 coinfected 50 left ventricular systolic 50 IELT 50 fraction LVEF 50 osteopenia 50 ALT elevations 50 hepatorenal syndrome 50 dapagliflozin plus 50 BRCA2 mutations 50 chorioamnionitis 50 extrapyramidal symptoms 50 neoplasias 50 azoospermia 50 cervical intraepithelial neoplasia 50 test OGTT 50 A1C levels 50 HBeAg negative 50 PROCTOCORT ® Suppository Hydrocortisone 50 fasting hyperglycemia 50 hip circumference 50 urate lowering therapy 50 μmol 50 nonobese patients 50 testicular tumors 50 detrusor 50 micromoles 50 oral glucose tolerance 50 Cmax 50 nephrolithiasis 50 milliliter ng ml 50 serum folate 49 plus GP IIb 49 abdominal girth 49 nondiabetic subjects 49 #-# mg dL 49 Fasting glucose levels 49 fractional shortening 49 ± #.#mm [001] 49 underwent radical prostatectomy 49 lipid lowering medications 49 Acetate Rectal Suppositories 49 overt hypothyroidism 49 HbA1c 49 dietary fiber intake 49 intact parathyroid hormone 49 abdominal obesity 49 cryptogenic 49 NYHA Class II 49 A1Cs 49 nonvertebral 49 statistical significance p 49 microgram kg 49 milliliters mL 49 macrovascular disease 49 lymph node metastasis 49 pulmonary arterial 49 baseline Hb 49 hemoglobin A1C 49 placebo p = 49 cm2 49 psychiatric comorbidities 49 dysfunction LVSD 49 unprotected vaginal 49 g carbo 49 cm 49 ALT flares 49 Flu Cy 49 extracapsular extension 49 tumor histology 49 #.#/#.# mm Hg [003] 49 CIN3 + 49 BLLs 49 UGT#A# * 49 ALND 49 isolated systolic hypertension 49 binary restenosis 49 habitual snorers 49 T1DM 49 LV ejection fraction 49 NIHSS 49 HAM D# scores 49 adenomas 49 non valvular atrial 49 telomere lengths 49 hemodynamically significant 49 NovoLog ® Mix 49 postop 49 arterial thromboembolic events 49 diabetes dyslipidemia 49 severe renal insufficiency 49 metformin IR 49 receiving ISENTRESS 49 IU ml 49 inhibin B 49 NYHA class 49 salmeterol fluticasone propionate 49 plasma glucose levels 49 LVEF 49 p = 49 benazepril 49 prepubertal 49 comorbid conditions 49 body fatness 49 shorter telomeres 49 heterozygotes 49 biphasic insulin aspart 49 abnormal glucose tolerance 49 CRP marker 49 confidence intervals CIs 49 pre menopausal 49 adiponectin levels 49 creatinine levels 49 Scale EDSS 49 serum PTH 49 #OHD 49 refractory ischemia 49 ertapenem 49 -#.# log# 49 Apolipoprotein E4 49 fragility fracture 49 symptomatic fibroids 49 antibody titers 49 nonfasting 49 abdominal visceral fat 49 min -1 49 maximal treadmill 49 mIU mL 49 p = NS 49 HMGA1 49 stomatitis pharyngitis 49 echocardiographic parameters 49 T2 lesions 49 waistlines shrank 49 OGTT 49 alcoholic fatty liver 49 ° ± 49 HBsAg 49 piotr.skolimowski @ thomson.com 49 nondrinkers 49 stage IIIb IV 49 oxycodone IR 49 nonexposed 49 μg doses 49 normal littermates 49 plasma lipids 49 DEXA scans 49 Taxus Stent 49 Asymptomatic 49 uM 49 renal cell carcinomas 49 abdominal pain flatulence 49 asymptomatic carotid stenosis 49 nM 49 ± 49 HBeAg negative patients 49 severe obstructive sleep 49 mg BID 49 osteoporotic fracture 49 rizatriptan 49 cGy 49 baseline neutrophil counts 49 log# 49 Non inferiority 49 causality incidence 49 mcg QD 49 HDL Cholesterol 49 ° preoperatively 49 BENICAR HCT 49 antihypertensive medications 49 serum magnesium 49 obstetric interventions 49 acrylamide intake 49 mg kg dose 49 seroprotection 49 ug kg 49 glomerular filtration rate 49 calcium oxalate stones 49 morphometric vertebral fractures 49 nonfasting triglycerides 49 hypokalemia 49 renal tumors 49 Scale EDSS score 49 placebo PBO 49 arterial thickening 49 neurodevelopmental impairment 49 atypical hyperplasia 49 clodronate 49 Waist circumference 49 baseline FEV1 49 oral antidiabetic medication 49 undergoing coronary angiography 49 biopsy Gleason 49 asymptomatic PAD 49 PUFA intake 49 femoral neck 49 glycosylated hemoglobin 49 perioperative complications 49 HBeAg positive 49 T2DM 49 prostate carcinoma 49 Å -1 49 hyperphenylalaninemia HPA due 49 p = .# [001] 49 iodine intake 49 #.#/#.# mm Hg [002] 49 cirrhotic patients 49 elevated IOP 49 allowance RDA 49 Nephrol Dial Transplant 49 lowest quintile 49 serum phosphate levels 49 serum HBV DNA 49 isoprostane 49 thyrotropin 49 CDAI 49 Diabetes mellitus 48 recurrent UTI 48 France CAC FCEc1 48 Expanded Disability Status 48 Calcium intake 48 C1 INH deficiency 48 calcium supplementation 48 CCyR 48 Hazard Ratio = 48 noted Darrel Drobnich 48 log# IU mL 48 Kcal 48 baseline CD4 48 acarbose 48 receiving Vectibix monotherapy 48 procollagen 48 mcg albinterferon alfa 2b 48 Kellgren Lawrence 48 cholesterol LDL C 48 aOR 48 Hemoglobin A1c HbA1c 48 3mg/kg 48 ACR# responses 48 revascularizations 48 magnesium intake 48 5-FU/LV 48 carotid artery intima media 48 leiomyomas 48 underwent CABG 48 g cm 48 colorectal neoplasms 48 nonmetastatic 48 cTnT 48 mg dosed twice 48 hyperplastic 48 nonischemic 48 corticosteroid dose 48 HIV seronegative 48 androgen excess 48 VLBW 48 elevated LDH 48 folic acid takers 48 glycosylated hemoglobin levels 48 abdominal distention 48 hemagglutination inhibition 48 QTcF 48 creatine phosphokinase 48 elevated LDL cholesterol 48 recurrent venous thromboembolism 48 rCBF 48 total thyroidectomy 48 plasma creatinine 48 thromboprophylaxis 48 singleton pregnancy 48 mercury mm Hg 48 PASI scores 48 prostate cancer CaP 48 lipid lowering agents 48 albuminuria 48 tPSA 48 IIIa inhibitors 48 dehydroepiandrosterone sulfate 48 mg simvastatin 48 radical nephrectomy 48 lumbar spine bone 48 amenorrhea 48 THIS STUDY 48 lopinavir r 48 BRCA gene mutations 48 hypertension hypercholesterolemia 48 thromboembolic 48 nodal metastases 48 premenopausal women 48 mean baseline A1C 48 Kidney Int 48 4mg/kg 48 breastfed exclusively 48 serum retinol 48 Postoperatively 48 diabetes mellitus DM 48 nadolol 48 creatinine 48 lifetime abstainers 48 COPD exacerbation 48 refractory NSCLC 48 transaminase 48 coronary stenosis 48 somatostatin analog 48 transfusion syndrome 48 microvascular complications 48 DAS# scores 48 LV dysfunction 48 LANTUS R 48 endometrial hyperplasia 48 lipid concentrations 48 Wistar rats 48 plasma homocysteine 48 Erythropoietic therapies may 48 #.#mg/kg [001] 48 QRS width 48 serum cholesterol 48 basal cell nevus syndrome 48 Mg Uk 48 systemic embolism 48 High Dose quadruples 48 Morbid obesity 48 estimated GFR 48 hypercalciuria 48 hMG 48 #.#g/day 48 SGRQ 48 pulmonary artery pressure 48 urinary excretion 48 multivariable adjusted 48 ovulatory cycles 48 arteriolar 48 serum homocysteine 48 Osteoporosis affects 48 endometriosis ovarian cysts 48 mg kg 48 XIENCE V PROMUS Stent 48 cerebrovascular events 48 Prehypertension 48 diabetes mellitus 48 serum insulin 48 RLAI 48 improves glycemic 48 serum phosphate 48 spine BMD 48 mCi m 2 48 serum triglyceride levels 48 #-# mg dl 48 tamsulosin 48 Valcyte tablets 48 C reactive protein 48 C#Y 48 TOTAL FG % 48 recurrent atrial fibrillation 48 loop diuretics 48 ug ml 48 uninfected infants 48 postintervention 48 Operative mortality 48 isoenzyme 48 thyroid stimulating hormone TSH 48 seroprotective 48 carotid artery blockage 48 HUL -#.# 48 attending antenatal clinics 48 mcg kg 48 oxygen saturations 48 pulmonary dysfunction 48 Estimated planetary 48 plasma homocysteine levels 48 vaginal hysterectomy 48 hypoglycemic episodes 48 VLDL cholesterol 48 Eur J Endocrinol 48 osmolality 48 Primary endpoints 48 lactate dehydrogenase LDH 48 Dr. Lars Sjostrom 48 left ventricular LV 48 MULTAQ 48 IQR = 48 fluticasone salmeterol 48 fasting serum 48 hepatic steatosis 48 postmenopausal 48 glucose tolerance 48 anogenital distance 48 polycystic ovary syndrome PCOS 48 dalteparin 48 radioiodine therapy 48 prevalent vertebral fracture 48 intraobserver 48 microscopic hematuria 48 develop premenopausal breast 48 ventricular myocardium 48 residual platelet reactivity 48 malignancy HCM 48 penetrance 48 postmenopausal osteoporotic women 48 Rod Outfit 48 cholesterols 48 complete cytogenetic response 48 ¡ À 48 LDL HDL ratio 48 overnight polysomnography 48 iobenguane 48 kcal kg 48 experienced virologic failure 48 esophageal squamous cell carcinoma 48 postmenopausal breast cancer 48 histologically confirmed 48 artery occlusion 48 locomotor activity 48 prior nephrectomy